Works matching AU Thompson, Alexander J.


Results: 82
    1
    2
    3

    Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varices.

    Published in:
    Liver International, 2016, v. 36, n. 2, p. 240, doi. 10.1111/liv.12916
    By:
    • Ding, Nik S.;
    • Nguyen, Tin;
    • Iser, David M.;
    • Hong, Thai;
    • Flanagan, Emma;
    • Wong, Avelyn;
    • Luiz, Lauren;
    • Tan, Jonathan Y. C.;
    • Fulforth, James;
    • Holmes, Jacinta;
    • Ryan, Marno;
    • Bell, Sally J.;
    • Desmond, Paul V.;
    • Roberts, Stuart K.;
    • Lubel, John;
    • Kemp, William;
    • Thompson, Alexander J.
    Publication type:
    Article
    4

    Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy.

    Published in:
    Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1352440
    By:
    • Hearps, Anna C.;
    • Vootukuru, Nikil;
    • Ebrahimnezhaddarzi, Salimeh;
    • Harney, Brendan L.;
    • Boo, Irene;
    • Nguyen, Long;
    • Pavlyshyn, Damian;
    • Dietze, Paul M.;
    • Drummer, Heidi E.;
    • Thompson, Alexander J.;
    • Jaworowski, Anthony;
    • Hellard, Margaret E.;
    • Sacks-Davis, Rachel;
    • Doyle, Joseph S.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    Treatment access is only the first step to hepatitis C elimination: experience of universal anti‐viral treatment access in Australia.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 9, p. 1223, doi. 10.1111/apt.15210
    By:
    • Doyle, Joseph S.;
    • Scott, Nick;
    • Sacks‐Davis, Rachel;
    • Pedrana, Alisa E.;
    • Thompson, Alexander J.;
    • Hellard, Margaret E.;
    • Hellard, Margaret;
    • Thompson, Alex;
    • Doyle, Joseph;
    • Dietze, Paul;
    • McBryde, Emma;
    • Sievert, William;
    • Stoove, Mark;
    • Higgs, Peter;
    • Petrie, Denis;
    • Vickerman, Peter
    Publication type:
    Article
    12

    The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services.

    Published in:
    PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0235445
    By:
    • Traeger, Michael W.;
    • Pedrana, Alisa E.;
    • van Santen, Daniela K.;
    • Doyle, Joseph S.;
    • Howell, Jessica;
    • Thompson, Alexander J.;
    • El-Hayek, Carol;
    • Asselin, Jason;
    • Polkinghorne, Victoria;
    • Membrey, Dean;
    • Bramwell, Fran;
    • Carter, Allison;
    • Guy, Rebecca;
    • Stoové, Mark A.;
    • Hellard, Margaret E.
    Publication type:
    Article
    13

    Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject Drugs.

    Published in:
    Clinical Infectious Diseases, 2020, v. 70, n. 9, p. 1900, doi. 10.1093/cid/ciz546
    By:
    • Wade, Amanda J;
    • Doyle, Joseph S;
    • Gane, Edward;
    • Stedman, Catherine;
    • Draper, Bridget;
    • Iser, David;
    • Roberts, Stuart K;
    • Kemp, William;
    • Petrie, Dennis;
    • Scott, Nick;
    • Higgs, Peter;
    • Agius, Paul A;
    • Roney, Janine;
    • Stothers, Lisa;
    • Thompson, Alexander J;
    • Hellard, Margaret E
    Publication type:
    Article
    14

    Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019 – CORRIGENDUM.

    Published in:
    2022
    By:
    • Lee Wilkinson, Anna;
    • Pedrana, Alisa;
    • Traeger, Michael W;
    • Asselin, Jason;
    • El-Hayek, Carol;
    • Nguyen, Long;
    • Polkinghorne, Victoria;
    • Doyle, Joseph S;
    • Thompson, Alexander J;
    • Howell, Jessica;
    • Scott, Nick;
    • Dimech, Wayne;
    • Guy, Rebecca;
    • Hellard, Margaret;
    • Stoové, Mark
    Publication type:
    Correction Notice
    15

    Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019.

    Published in:
    Epidemiology & Infection, 2022, v. 150, p. 1, doi. 10.1017/S0950268821002624
    By:
    • Lee Wilkinson, Anna;
    • Pedrana, Alisa;
    • Traeger, Michael W.;
    • Asselin, Jason;
    • El-Hayek, Carol;
    • Nguyen, Long;
    • Polkinghorne, Victoria;
    • Doyle, Joseph S.;
    • Thompson, Alexander J.;
    • Howell, Jessica;
    • Scott, Nick;
    • Dimech, Wayne;
    • Guy, Rebecca;
    • Hellard, Margaret;
    • Stoové, Mark
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    IL28 B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α.

    Published in:
    Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 5, p. 861, doi. 10.1111/jgh.12110
    By:
    • Holmes, Jacinta A;
    • Nguyen, Tin;
    • Ratnam, Dilip;
    • Heerasing, Neel M;
    • Tehan, Jane V;
    • Bonanzinga, Sara;
    • Dev, Anouk;
    • Bell, Sally;
    • Pianko, Stephen;
    • Chen, Robert;
    • Visvanathan, Kumar;
    • Hammond, Rachel;
    • Iser, David;
    • Rusli, Ferry;
    • Sievert, William;
    • Desmond, Paul V;
    • Bowden, D Scott;
    • Thompson, Alexander J
    Publication type:
    Article
    31

    Host genomics and HCV treatment response.

    Published in:
    Journal of Gastroenterology & Hepatology, 2012, v. 27, n. 2, p. 212, doi. 10.1111/j.1440-1746.2011.06918.x
    By:
    • Clark, Paul J;
    • Thompson, Alexander J
    Publication type:
    Article
    32

    Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.

    Published in:
    Journal of Gastroenterology & Hepatology, 2011, v. 26, n. 7, p. 1182, doi. 10.1111/j.1440-1746.2011.06722.x
    By:
    • Patel, Keyur;
    • Thompson, Alexander J;
    • Chuang, Wan-Long;
    • Lee, Chuan-Mo;
    • Peng, Chen-Yuan;
    • Shanmuganathan, Ganesananthan;
    • Thongsawat, Satawat;
    • Tanwandee, Tawesak;
    • Mahachai, Varocha;
    • Pramoolsinsap, Chutima;
    • Cho, Mong;
    • Han, Kwang Hyup;
    • Shah, Samir R;
    • Foster, Graham R;
    • Clark, Paul J;
    • Pulkstenis, Erik;
    • Subramanian, G. Mani;
    • McHutchison, John G
    Publication type:
    Article
    33
    34
    35
    36

    Australian consensus recommendations for the management of hepatitis B.

    Published in:
    Medical Journal of Australia, 2022, v. 216, n. 9, p. 478, doi. 10.5694/mja2.51430
    By:
    • Lubel, John S;
    • Strasser, Simone I;
    • Thompson, Alexander J;
    • Cowie, Benjamin C;
    • MacLachlan, Jennifer;
    • Allard, Nicole L;
    • Holmes, Jacinta;
    • Kemp, William W;
    • Majumdar, Avik;
    • Iser, David;
    • Howell, Jess;
    • Matthews, Gail V
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44

    Care Navigation Increases Initiation of Hepatitis C Treatment After Release From Prison in a Prospective Randomized Controlled Trial: The C-LINK Study.

    Published in:
    Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac350
    By:
    • Papaluca, Timothy;
    • Craigie, Anne;
    • McDonald, Lucy;
    • Edwards, Amy;
    • Winter, Rebecca;
    • Hoang, Annabelle;
    • Pappas, Alex;
    • Waldron, Aoife;
    • McCoy, Kelsey;
    • Stoove, Mark;
    • Doyle, Joseph;
    • Hellard, Margaret;
    • Holmes, Jacinta;
    • MacIsaac, Michael;
    • Desmond, Paul;
    • Iser, David;
    • Thompson, Alexander J
    Publication type:
    Article
    45

    The impact of point‐of‐care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study.

    Published in:
    Journal of Viral Hepatitis, 2022, v. 29, n. 5, p. 375, doi. 10.1111/jvh.13664
    By:
    • Howell, Jessica;
    • Traeger, Michael W.;
    • Williams, Bridget;
    • Layton, Chloe;
    • Doyle, Joseph S.;
    • Latham, Ned;
    • Draper, Bridget;
    • Bramwell, Frances;
    • Membrey, Dean;
    • McPherson, Maggie;
    • Roney, Janine;
    • Stoové, Mark;
    • Thompson, Alexander J.;
    • Hellard, Margaret E.;
    • Pedrana, Alisa
    Publication type:
    Article
    46
    47
    48
    49
    50

    Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis.

    Published in:
    JAMA: Journal of the American Medical Association, 2015, v. 313, n. 17, p. 1736, doi. 10.1001/jama.2015.3868
    By:
    • Muir, Andrew J.;
    • Poordad, Fred;
    • Lalezari, Jacob;
    • Everson, Gregory;
    • Dore, Gregory J.;
    • Herring, Robert;
    • Sheikh, Aasim;
    • Kwo, Paul;
    • Hézode, Christophe;
    • Pockros, Paul J.;
    • Tran, Albert;
    • Yozviak, Joseph;
    • Reau, Nancy;
    • Ramji, Alnoor;
    • Stuart, Katherine;
    • Thompson, Alexander J.;
    • Vierling, John;
    • Freilich, Bradley;
    • Cooper, James;
    • Ghesquiere, Wayne
    Publication type:
    Article